Published in Neoplasma on January 01, 2013
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. Int J Clin Exp Pathol (2014) 0.79
S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. Int J Clin Exp Pathol (2014) 0.75
Fungaemia due to Fusarium spp. in cancer patients. J Hosp Infect (1997) 1.11
Nosocomial bacterial and fungal meningitis in cancer patients. Support Care Cancer (1995) 0.96
Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide. Proc Natl Acad Sci U S A (2001) 0.93
Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients? J Chemother (1997) 0.90
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome. J Antimicrob Chemother (1998) 0.87
First report of vancomycin-resistant Streptococcus mitis bacteremia in a leukemic patient after prophylaxis with quinolones and during treatment with vancomycin. J Chemother (1996) 0.87
Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis. Microb Drug Resist (1997) 0.87
Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer (1996) 0.86
Nosocomial catheter-associated Flavobacterium odoratum bacteraemia in cancer patients. J Med Microbiol (1998) 0.85
Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J Chemother (1998) 0.84
Fatal Trichosporon pullulans breakthrough fungemia in cancer patients: report of three patients who failed on prophylaxis with itraconazole. Infection (1996) 0.84
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution. Acta Oncol (1997) 0.81
Prospective study of nosocomial fungal meningitis in children--report of 10 cases. Scand J Infect Dis (1998) 0.81
Fungemia in cancer patients undergoing chemotherapy versus surgery: risk factors, etiology and outcome. Scand J Infect Dis (1997) 0.81
Identification of phenylethanolamine N-methyltransferase gene expression in stellate ganglia and its modulation by stress. J Neurochem (2006) 0.80
Funguria in cancer patients: analysis of risk factors, clinical presentation and outcome in 50 patients. Infection (1997) 0.80
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication. Chemotherapy (1992) 0.80
Breakthrough fungemia appearing during empiric therapy with amphotericin B. Chemotherapy (1997) 0.78
The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis. Neoplasma (2007) 0.78
Imipenen-resistant Ps. aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res (1996) 0.77
Bacteremia due to teicoplanin-resistant and vancomycin-susceptible Staphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin. Infection (1997) 0.76
Novel and recurrent germline alterations in the MLH1 and MSH2 genes identified in hereditary nonpolyposis colorectal cancer patients in Slovakia. Neoplasma (2006) 0.76
STK11/LKB1 germline mutations in the first Peutz-Jeghers syndrome patients identified in Slovakia. Neoplasma (2007) 0.75
Postoperative bacteremia in cancer patients with solid tumors undergoing surgery: risk factors, etiology and outcome in 276 patients. Support Care Cancer (1997) 0.75
An unusual presentation of testicular cancer. Bratisl Lek Listy (2008) 0.75
Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia. Support Care Cancer (1996) 0.75
Bacteremia due to Enterobacter spp. in cancer patients--analysis of 51 episodes. Int J Antimicrob Agents (1997) 0.75
Idiopatic lobular necrotizing paniculitis. Bratisl Lek Listy (2014) 0.75
Fungemia in children with neoplastic diseases. Pediatr Infect Dis J (1998) 0.75
Circulating tumour cells in breast cancer--review. Klin Onkol (2010) 0.75
[Fluorine in drinking water in East Slovakia]. Gig Sanit (1975) 0.75
[Initial experience with fluconazole, a new triazole antimycotic agent, in oncology patients]. Cas Lek Cesk (1990) 0.75
Polymicrobial bacteremia in cancer patients: analysis of risk factors, etiology and outcome in 214 episodes. Int J Antimicrob Agents (1996) 0.75
Once-daily pefloxacin + teicoplanin vs netilmicin + teicoplanin in empirical therapy for fever and neutropenia. Drugs (1995) 0.75
Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients. Neoplasma (2009) 0.75
Analysis of radiation-induced angiosarcoma of the breast. Bratisl Lek Listy (2014) 0.75
Predictors of inferior outcome in community acquired bacterial meningitis. Neuro Endocrinol Lett (2007) 0.75
Novel approaches in evaluation of pathogenicity of single-base exonic germline changes involving the mismatch repair genes MLH1 and MSH2 in diagnostics of Lynch syndrome. Neoplasma (2008) 0.75
Three fatal cases of disseminated mucormycosis associated with respiratory distress syndrome and shock in patients with hematologic malignancies. Infection (1992) 0.75
Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. J Chemother (1999) 0.75
Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population. Neoplasma (2009) 0.75
Nosocomial meningitis caused by Staphylococcus other than S. aureus in children: multicentre study. Neuro Endocrinol Lett (2007) 0.75
Increasing incidence of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in a cancer centre over a seven-year period. J Hosp Infect (1997) 0.75
Bacteremia in cancer patients with solid tumors undergoing chemotherapy versus surgery: risk factors, etiology and outcome in 276 patients. J Chemother (1997) 0.75
Fluconazole in the treatment of mycotic oropharyngeal stomatitis and esophagitis in neutropenic cancer patients. Chemotherapy (1991) 0.75
Growth factors and hematopoietic recovery. Med Oncol (1994) 0.75
Breakthrough nosocomial bacteraemia due to teicoplanin-resistant Staphylococcus haemolyticus in five patients with acute leukaemia. J Hosp Infect (1997) 0.75
Vancomycin plus imipenem ceftazidime or ciprofloxacin in second line therapy in patients with febrile neutropenia not responding to first line therapy. Chemotherapy (1996) 0.75